Ligufalimab and Cadonilimab in Advanced Liver Cancers
Status:
RECRUITING
Trial end date:
2030-05-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to find out if the combination of Ligufalimab and Cadonilimab are effective in treating advanced hepatobiliary cancers that have failed prior therapy.